Irena Melnikova is a Partner at Pfizer Ventures and Executive Director of Worldwide Business Development. She has over 20 years of experience in biopharma and finance.
At firms with a similar stage, sector and check size.




One email when Irena's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckIrena Melnikova is a Partner at Pfizer Ventures and Executive Director of Worldwide Business Development. She has over 20 years of experience in biopharma and finance.
Irena Melnikova invests through Pfizer Ventures, which writes checks of $3M to $30M at seed, series a, series b.
A warm intro from a founder Pfizer Ventures backed works best.
TVM Capital; Sanofi; Managing Director, Biopharma Investment Banking at Leerink Partners; Chief Financial Officer at Umoja Biopharma; Executive Director at Worldwide Business Development.
Last updated 2026-10-15. Is this you? Ask for a correction.